Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shah SV et al. – There is a large amount of experimental evidence for an increase of labile iron in a wide variety of models of kidney disease. Additionally, iron chelators provide protection, indicating an important role of labile iron in these diseases. These observations suggest that iron chelators may provide a new modality of prevention and treatment of kidney disease.

Related Articles

Iron-Refractory Iron Deficiency Anemia
Seminars in Hematology, 10/05/09    Relevance Score: 48%

Correcting Iron-Restricted Erythropoiesis and Improving Anemia in Patients on Hemodialysis:Practical Tips that Can Make a Difference
Nephrology Nursing Journal, 10/02/09    Relevance Score: 48%

Iron-Fortified Rice Is As Efficacious As Supplemental Iron Drops in Infants and Young Children
The Journal of Nutrition, 11/06/09    Relevance Score: 47%

Update on the use of deferasirox in the management of iron overload
Therapeutics and Clinical Risk Management, 11/05/09    Relevance Score: 47%

Iron Sequestration and Anemia of Inflammation
Seminars in Hematology, 10/06/09    Relevance Score: 46%

Today in Chronic Dz/Renal Failure...keeping you current

The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
Journal of the American Society of Nephrology, 11/25/09

Prevention of acute kidney injury and protection of renal function in the intensive care unit
Intensive Care Medicine, 11/23/09

Frasier syndrome, a potential cause of end-stage renal failure in childhood
Pediatric Nephrology, 11/23/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address